MYX mayne pharma group limited
Add to My Watchlist 0.40% ! $4.97

Since its first FDA application way back in March 2018 Richards...

  1. KamikazePilot
    1,479 Posts.
    lightbulb Created with Sketch. 291
    clock Created with Sketch.
    21/07/22
    16:55
    Post #: 62658838
    Since its first FDA application way back in March 2018 Richards assured us there were no significant issues , after further unsuccessful submissions Richards informed us "he was confident we can address issues raised in a timely manner" . In other words doesn't have clue how long approval might take .
    MYX Price at posting: 32.0¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

AII Analyst Buy Rating: Leading the Charge in Securing the Tungsten Supply Chain
right-arrow Created with Sketch.
NEWS DeSoto Granted New Project in Guinea's Siguiri Basin
right-arrow Created with Sketch.
NEWS Opportunities like this don’t last—register and get started today
right-arrow Created with Sketch.
NEWS The Watchlist - Hear from ASX Leaders!
right-arrow Created with Sketch.
NEWS Investor education equals superior returns
right-arrow Created with Sketch.
NEWS Oz core inflation at 2.7%; August cut odds still unclear; ASX200 rises
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$4.97 		Change
0.020(0.40%) 		Mkt cap ! $403.7M
Open High Low Value Volume
$4.97 $5.00 $4.95 $246.9K 49.66K

Buyers (Bids)

No. Vol. Price($)
3 363 $4.96
 

Sellers (Offers)

Price($) Vol. No.
$4.97 640 1
View Market Depth
Last trade - 11.39am 01/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.